Compare BridgeBio Pharma Inc (BBIO) vs Nutrien Ltd (NTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Nutrien Ltd — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while Nutrien Ltd trades at $67.7 (market cap $31.60B). The key difference: Nutrien Ltd is the larger of the two by market cap, and Nutrien Ltd pays a 3.32% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | NTR | |
|---|---|---|
Market Cap | $16.61B | $31.60B |
Sector | Health | Basic Materials |
52-Week High | $90.17 | $83.94 |
52-Week Low | $47.29 | $53.64 |
Enterprise Value | $18.16B | $43.40B |
Dividend Yield | — | 3.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Nutrien Ltd
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients--nitrogen, potash, and phosphate--although its main focus is potash, where it is the global leader in installed capacity with roughly 20% share. The company is also the largest agricultural retailer in the United States, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
Read more on NTR →
